These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16098683)

  • 1. Effects of 5-HT1A and 5-HT2A receptor stimulation on temporal differentiation performance in the fixed-interval peak procedure.
    Asgari K; Body S; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
    Behav Processes; 2006 Feb; 71(2-3):250-7. PubMed ID: 16098683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 5-HT
    Fletcher PJ; Zeeb FD; Browne CJ; Higgins GA; Soko AD
    Psychopharmacology (Berl); 2017 Mar; 234(5):889-902. PubMed ID: 28097374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a 5-HT2 receptor agonist, DOI (2,5-dimethoxy-4-iodoamphetamine), and antagonist, ketanserin, on the performance of rats on a free-operant timing schedule.
    Body S; Kheramin S; Ho MY; Miranda F; Bradshaw CM; Szabadi E
    Behav Pharmacol; 2003 Dec; 14(8):599-607. PubMed ID: 14665977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fenfluramine on free-operant timing behaviour: evidence for involvement of 5-HT2A receptors.
    Body S; Kheramin S; Ho MY; Miranda Herrera F; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2004 Nov; 176(2):154-65. PubMed ID: 15103450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo.
    Zhang Y; Gray TS; D'Souza DN; Carrasco GA; Damjanoska KJ; Dudas B; Garcia F; Zainelli GM; Sullivan Hanley NR; Battaglia G; Muma NA; Van de Kar LD
    J Pharmacol Exp Ther; 2004 Jul; 310(1):59-66. PubMed ID: 15064330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of clozapine and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on progressive ratio schedule performance: evidence against the involvement of 5-HT1A receptors in the behavioural effects of clozapine.
    Zhang Z; Rickard JF; Body S; Asgari K; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2005 Sep; 181(2):381-91. PubMed ID: 15830225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of central 5-hydroxytryptamine depletion to alter the effect of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on timing performance on the free-operant psychophysical procedure.
    Body S; Chiang TJ; Mobini S; Ho MY; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2001 Nov; 158(3):305-13. PubMed ID: 11713621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
    Body S; Asgari K; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2005 Sep; 181(2):289-98. PubMed ID: 15864559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT1A receptor agonist (8-OH-DPAT) and 5-HT2 receptor agonist (DOI) disrupt the non-cognitive performance of rats in a working memory task.
    Ruotsalainen S; MacDonald E; Koivisto E; Stefanski R; Haapalinna A; Riekkinen P; Sirviö J
    J Psychopharmacol; 1998; 12(2):177-85. PubMed ID: 9694031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
    Freo U; Merico A; Ermani M; Ori C
    Brain Res; 2010 Jun; 1335():24-34. PubMed ID: 20381465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that the effect of 5-HT2 receptor stimulation on temporal differentiation is not mediated by receptors in the dorsal striatum.
    Body S; Asgari K; Cheung TH; Bezzina G; Fone KF; Glennon JC; Bradshaw CM; Szabadi E
    Behav Processes; 2006 Feb; 71(2-3):258-67. PubMed ID: 16326032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats.
    Kitamura Y; Kitagawa K; Fujitani Y; Shibata K; Araki H; Sendou T; Gomita Y
    Biol Pharm Bull; 2007 Jan; 30(1):117-20. PubMed ID: 17202670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain.
    Tilakaratne N; Friedman E
    Eur J Pharmacol; 1996 Jun; 307(2):211-7. PubMed ID: 8832223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism by WAY-100635 of the effects of 8-OH-DPAT on performance on a free-operant timing schedule in intact and 5-HT-depleted rats.
    Body S; Kheramin S; Mobini S; Ho MY; Velazquez-Martinez DN; Bradshaw CM; Szabadi E
    Behav Pharmacol; 2002 Dec; 13(8):603-14. PubMed ID: 12478210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 5-HT2A receptor stimulation on the discrimination of durations by rats.
    Asgari K; Body S; Bak VK; Zhang ZQ; Rickard JF; Glennon JC; Fone KC; Bradshaw CM; Szabadi E
    Behav Pharmacol; 2006 Feb; 17(1):51-9. PubMed ID: 16377963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of 5-HT receptor agonists on operant response in rats under DRL 10-s and DRL 30-s schedules.
    Liao RM; Chang YH
    Proc Natl Sci Counc Repub China B; 2001 Oct; 25(4):223-32. PubMed ID: 11699570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
    Gomes KS; Nunes-De-Souza RL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1261-9. PubMed ID: 19625008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food restriction and streptozotocin treatment decrease 5-HT1A and 5-HT2A receptor-mediated behavioral effects in rats.
    Li JX; France CP
    Behav Pharmacol; 2008 Jul; 19(4):292-7. PubMed ID: 18622176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the Functional Cross-Talk between Brain 5-HT1A and 5-HT2A Receptors].
    Naumenko VS; Bazovkina DV; Kondaurova EM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2015; 65(2):240-7. PubMed ID: 26080602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.